Talphera, Inc
Talphera develops Niyad®, a lyophilized nafamostat formulation for use as an anticoagulant in extracorporeal circuits.
10-QAug 13Latest SEC filing, period to Jun 30
Aug 12Latest story
August 2026
Sign inSign inTalphera develops Niyad®, a lyophilized nafamostat formulation for use as an anticoagulant in extracorporeal circuits.